Corticosteroids and pneumonia: Time to change practice

The Lancet

Volumn 385, Issue 9977, 2015, Pages 1484-1485

  Annane, Djillali ^a  

^a LABORATOIRE DES SCIENCES DU CLIMAT ET DE L ENVIRONNEMENT   (France)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CORTICOSTEROID; INTERLEUKIN 10; PREDNISONE; ANTIINFLAMMATORY AGENT;

ANTIBIOTIC THERAPY; CLINICAL PRACTICE; COMMUNITY ACQUIRED PNEUMONIA; DISEASE SEVERITY; HEALTH CARE COST; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INTENSIVE CARE UNIT; LENGTH OF STAY; MORBIDITY; NOTE; PRIORITY JOURNAL; FEMALE; MALE; PNEUMONIA;

ANTI-INFLAMMATORY AGENTS; FEMALE; HUMANS; MALE; PNEUMONIA; PREDNISONE;

EID: 84928414786     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(14)62391-6     Document Type: Note

References (14)

1. GBD 2013 Mortality and Causes of Death Collaborators Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013 Lancet 385 2015 117 171
2. JM Wortham, DJ Shapiro, AL Hersh, LA Hicks Burden of ambulatory visits and antibiotic prescribing patterns for adults with community-acquired pneumonia in the United States, 1998 through 2009 JAMA Intern Med 174 2014 1520 1522
3. J Broulette, B Pyenson, R Sato, H Yu, K Iwasaki the incidence rate and economic burden of community-acquired pneumonia in a working-age population Am Health Drug Benefits 6 2013 494 503
4. M Woodhead, F Blasi, S Ewig Joint Taskforce of the European Respiratory Society and European Society for Clinical Microbiology and Infectious Diseases Guidelines for the management of adult lower respiratory tract infections - full version Clin Microbiol Infect 17 suppl 6 2011 E1 59
5. CA Blum, N Nigro, M Briel et al. Adjunct prednisone therapy for patients with community-acquired pneumonia: a multicentre, double-blind, randomised, placebo-controlled trial Lancet 2015 published online Jan 19. http://dx.doi.org/10.1016/S0140-6736(14)62447-8
6. NA Sabry, E El-Din Omar Corticosteroids and ICU course of community acquired pneumonia in Egyptian settings Pharmacol Pharm 2 2011 73 81
7. M Confalonieri, R Urbino, A Potena et al. Hydrocortisone infusion for severe community-acquired pneumonia: a preliminary randomized study Am J Respir Crit Care Med 171 2005 242 248
8. K Mikami, M Suzuki, H Kitagawa et al. Efficacy of corticosteroids in the treatment of community-acquired pneumonia requiring hospitalization Lung 185 2007 249 255
9. SC Meijvis, H Hardeman, HH Remmelts et al. Dexamethasone and length of hospital stay in patients with community-acquired pneumonia: a randomised, double-blind, placebo-controlled trial Lancet 377 2011 2023 2030
10. Polverino E, Torres A, Sibila O, et al. Corticosteroids in severe community-acquired pneumonia: a multicenter, randomized, double-blind, placebo-controlled trial. American Thoracic Society international Conference, San Diego, USA, May 16-21, 2014. C105.
11. D Snijders, JM Daniels, CS de Graaff, TS van der Werf, WG Boersma Efficacy of corticosteroids in community acquired pneumonia - a randomized double blinded clinical trial Am J Respir Crit Care Med 181 2010 975 982
12. H Ostermann, J Garau, J Medina, E Pascual, K McBride, F Blasi REACH study group Resource use by patients hospitalized with community-acquired pneumonia in Europe: analysis of the REACH study BMC Pulm Med 14 2014 36
13. F Walsh Antibiotic resistance: Cameron warns of medical "dark ages" BBC News July 2, 2014 http://www.bbc.co.uk/news/health-28098838 (accessed Jan 9, 2015).
14. D Annane, T Sharshar Cognitive decline after sepsis Lancet Respir Med 3 2015 61 69